Furthermore, mice immunised with either AntpMUC1Kb or TATMUC1Kb peptides generated strong MUC1-specific IFN-γ responses and inhibited the growth of B16-MUC1 tumours (Figure 7 and Figure 8). The gene discussed is MUC1; the disease is neoplasm.